Colony collapse disorder may affect complementary and alternative medicine.

Recent trends and important developments in propolis research. Evid Based Complement Alternat Med (2005) 2.25

Origin and Chemical Variation of Brazilian Propolis. Evid Based Complement Alternat Med (2005) 1.91

Bioprospecting: a CAM Frontier. Evid Based Complement Alternat Med (2005) 1.82

Entomology. The case of the empty hives. Science (2007) 1.67

Neuroprotection by Brazilian Green Propolis against In vitro and In vivo Ischemic Neuronal Damage. Evid Based Complement Alternat Med (2005) 1.59

Bioactive constituents of brazilian red propolis. Evid Based Complement Alternat Med (2006) 1.56

Plant Origin of Green Propolis: Bee Behavior, Plant Anatomy and Chemistry. Evid Based Complement Alternat Med (2005) 1.39

Comparison of Radical Scavenging Activity, Cytotoxic Effects and Apoptosis Induction in Human Melanoma Cells by Taiwanese Propolis from Different Sources. Evid Based Complement Alternat Med (2004) 1.38

Brazilian green propolis protects against retinal damage in vitro and in vivo. Evid Based Complement Alternat Med (2006) 1.14

Green brazilian propolis action on macrophages and lymphoid organs of chronically stressed mice. Evid Based Complement Alternat Med (2008) 0.99

Effect of bee venom on aromatase expression and activity in leukaemic FLG 29.1 and primary osteoblastic cells. J Ethnopharmacol (2005) 0.84

CAM, eCAM, Bioprospecting: The 21st Century Pyramid. Evid Based Complement Alternat Med (2005) 2.68

Drug Discovery, CAM and Natural Products. Evid Based Complement Alternat Med (2004) 2.64

Bioprospecting: a CAM Frontier. Evid Based Complement Alternat Med (2005) 1.82

Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med (2011) 1.49

The danger theory: 20 years later. Front Immunol (2012) 1.38

Characterization of cells with different mitochondrial membrane potential during apoptosis. Cytometry A (2005) 1.35

Commentary on Traditional and Modern Biomedical Prospecting: Part II-The Benefits by Werner E.G. Muller, Heinz C. Schroder, Matthias Wiens, Sanja Perovic-Ottstadt, Renato Batel and Isabel M. Muller: Anti-protozoa and antiviral activities of non-cytotoxic truncated and variant analogues of mussel defensin by P. Roch, A. Beschin and E. Bernard. Evid Based Complement Alternat Med (2004) 1.14

Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic Res (2005) 1.07

Regional Strength in CAM. Evid Based Complement Alternat Med (2006) 1.04

Sex-specific effects of carotenoid intake on the immunological response to allografts in guppies (Poecilia reticulata). Proc Biol Sci (2004) 1.00

Nervous, endocrine, immune systems as a target for complementary and alternative medicine. Adv Exp Med Biol (2004) 0.92

ECAM is waiting for eCAM. Evid Based Complement Alternat Med (2005) 0.91

Hypothetical mode of action of earthworm extract with hepatoprotective and antioxidant properties. J Zhejiang Univ Sci B (2008) 0.89

Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. Leuk Res (2008) 0.87

eCAM: On To Year 4. Evid Based Complement Alternat Med (2006) 0.87

Toll-like receptor genes (TLRs) from Capitella capitata and Helobdella robusta (Annelida). Dev Comp Immunol (2007) 0.86

Is there room for paradox in CAM? Evid Based Complement Alternat Med (2007) 0.86

Stem cells and CAM. Evid Based Complement Alternat Med (2006) 0.85

Evaluation of an innate immune reaction to parasites in earthworms. J Invertebr Pathol (2004) 0.84

Leech responses to tissue transplantation. Tissue Cell (2003) 0.82

Monoclonal antibodies identify four distinct annelid leukocyte markers. Dev Comp Immunol (2004) 0.80

Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin Diagn Lab Immunol (2004) 0.80

Mass spectrometric analyses of CL(39), CL(41) and H(1), H(2), H(3) confirm identity with fetidin and lysenin produced by earthworm leukocytes. Dev Comp Immunol (2003) 0.79

Leeches: immune response, angiogenesis and biomedical applications. Curr Pharm Des (2003) 0.78

eCAM: moving forward. Evid Based Complement Alternat Med (2007) 0.78

eCAM: Darwin and Metchnikoff. Evid Based Complement Alternat Med (2009) 0.78

Earthworm leukocytes react with different mammalian antigen-specific monoclonal antibodies. Zoology (Jena) (2002) 0.77

eCAM: Clinical Analyses and Increasing Visibility. Evid Based Complement Alternat Med (2009) 0.77

Immune systems, geographic information systems (GIS), environment and health impacts. J Toxicol Environ Health B Crit Rev (2004) 0.77

Coelomocyte locomotion in the sipunculan Themiste petricola induced by exogenous and endogenous chemoattractants: role of a CD44-like antigen--HA interaction. J Invertebr Pathol (2002) 0.77

eCAM benefits from diversity that derives from CAM. Evid Based Complement Alternat Med (2005) 0.77

Marine biotechnology. Evid Based Complement Alternat Med (2011) 0.75

Neuroendocrine mechanisms of acupuncture. Evid Based Complement Alternat Med (2012) 0.75

Pomegranate: its health and biomedical potential. Evid Based Complement Alternat Med (2013) 0.75

Medical ethnobiology and ethnopharmacology in latin america. Evid Based Complement Alternat Med (2012) 0.75

Brian Solomon. Dev Comp Immunol (2015) 0.75

Identification of diseases that may be targets for complementary and alternative medicine (CAM). Adv Exp Med Biol (2004) 0.75